NDC 52945-069

NDC 52945-069

NDC 52945-069 is a Injection, Suspension, Liposomal in the Drug For Further Processing category. It is labeled and distributed by Patheon Uk Limited.

Product ID52945-069_29ab6e9f-c760-4e9e-966f-c6a6be6fffc7
NDC52945-069
Product TypeDrug For Further Processing
Proprietary NameNDC 52945-069
Dosage FormInjection, Suspension, Liposomal
Marketing Start Date2012-01-01
Marketing Category/ DRUG FOR FURTHER PROCESSING
Labeler NamePatheon UK Limited

Packaging

NDC 52945-069-00

2 TRAY in 1 CASE (52945-069-00) > 105 VIAL in 1 TRAY > 20 mL in 1 VIAL
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
BUPIVACAINE13.3 mg/mL

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.